BIRCH TRITERPENES: Pharmaceutical manufacturers, suppliers, and wholesalers

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Chiesi	FILSUVEZ	birch triterpenes	GEL;TOPICAL	215064	NDA	Chiesi USA, Inc.	10122-310-02	1 TUBE in 1 CARTON (10122-310-02) / 23.4 g in 1 TUBE (10122-310-01)	2024-02-22
Chiesi	FILSUVEZ	birch triterpenes	GEL;TOPICAL	215064	NDA	Amryt Pharmaceuticals DAC	76431-310-01	1 TUBE in 1 CARTON (76431-310-01) / 23.4 g in 1 TUBE	2024-02-22
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: July 27, 2025

Introduction

Birch triterpenes are a class of bioactive compounds derived primarily from Betula species, notably Betula pendula and Betula pubescens. Renowned for their therapeutic and pharmacological properties, these compounds have gained prominence in the pharmaceutical, nutraceutical, and cosmeceutical sectors. Their anti-inflammatory, anti-cancer, antimicrobial, and hepatoprotective activities make them valuable building blocks or active ingredients in drug development.

This article provides comprehensive insights into key suppliers of birch triterpenes, their sourcing strategies, manufacturing capabilities, and their supply chain status. It aims to assist pharmaceutical entities, research organizations, and investors in identifying reliable partners for procurement.

Understanding Birch Triterpenes: Composition and Significance

Birch triterpenes predominantly include compounds such as betulin, betulinic acid, and lupeol. Betulin is the most abundant, often constituting up to 30% of birch bark’s extract. These triterpenes are extracted through solvent or supercritical CO2 extraction processes from birch bark, which is abundant in forests across Europe and North America. Their pharmacological importance is well-documented:

Betulin exhibits anti-inflammatory, antiviral, and antiparasitic effects.
Betulinic acid has demonstrated anti-melanoma and anti-HIV activities.
Lupeol possesses anti-inflammatory and anti-malarial properties.

Their complex molecular structure necessitates specialized extraction and purification techniques, influencing supplier capabilities.

Market Overview and Demand Dynamics

The increasing interest in plant-derived pharmaceuticals, fueled by the shift toward natural therapeutics, has escalated demand for birch triterpenes. The global betulin market alone was valued at approximately USD 47 million in 2021 and is projected to grow at CAGR exceeding 7% through 2030 (Source: MarketsandMarkets). The expanding pipeline of birch triterpene-based formulations underscores the need for high-quality and reliable suppliers.

Leading Suppliers of Birch Triterpenes

1. OlbrichtArom

Headquarters: Germany
Specializations: Botanical extracts, phytosterols, and triterpenes
Capabilities: Offers standardized extracts rich in betulin and betulinic acid derived from birch bark. Implements solvent extraction, supercritical CO2, and chromatographic purification techniques.
Certifications: GMP, ISO 9001, Organic certifications (EU Organic, USDA Organic)
Supply Scope: Bulk quantities and custom formulations; ongoing R&D collaborations for pharmaceutical-grade compounds.

2. Phytolab

Headquarters: Germany
Specializations: Natural extracts, phytochemicals with focus on betulin and related triterpenoids
Capabilities: Provides high-purity betulin (>95%) suitable for pharmaceutical applications. Uses eco-friendly extraction methods ensuring sustainability and batch consistency.
Certifications: GMP, Organic, ISO standards
Supply Scope: Commercial quantities, research-grade extracts, custom specifications.

3. Indena S.p.A.

Headquarters: Italy
Specializations: Botanical extracts for pharmaceutical and nutraceutical markets
Capabilities: Extracts standardization services, provides betulin-based extracts with high purity. Extensive experience in proprietary extraction and purification processes.
Certifications: GMP, ISO 9001, Ecomark
Supply Scope: Bulk ingredients, pilot programs, private label development.

4. Green Forest Ltd. (China)

Headquarters: China
Specializations: Birch bark extracts, natural products supply chain
Capabilities: Mass production of birch bark-derived triterpene extracts, including betulin and betulinic acid, leveraging extensive forestry resources. Uses solvent and supercritical CO2 extraction.
Certifications: GMP, ISO standards, Factory audit reports
Supply Scope: Large-scale volume supply, contract manufacturing.

5. Siberian Environmental

Headquarters: Russia
Specializations: Wild harvest and sustainable extraction of birch bark
Capabilities: Focuses on natural, wild-harvested material, emphasizing ecological sustainability. Offers extracts with variable betulin content, customizable for pharmaceutical quality.
Certifications: Organic, GMP in progress
Supply Scope: Medium to large quantities for research and early-phase clinical trials.

Key Considerations When Sourcing Birch Triterpenes

Extraction Methodology: Supercritical CO2 extraction yields high-purity betulin without solvent residues—a critical factor for pharmaceutical applications. Suppliers utilizing eco-friendly methods often align better with regulatory standards.
Quality Certifications: ISO 9001, GMP compliance, and organic certifications (EU Organic, USDA Organic) are paramount for pharma-grade materials.
Purity and Standardization: Ensure suppliers provide certificates of analysis (CoA) with detailed purity levels, batch consistency, and active compound concentrations.
Sustainable and Ethical Sourcing: Preference for suppliers employing sustainable harvesting practices, especially critical given environmental concerns and regulatory scrutiny.
Regulatory Compliance: Suppliers must adhere to pharmaceutical manufacturing standards, including cGMP, and comply with regional export/import regulations.

Emerging Suppliers and Innovators

With the rising demand, several startups and biotech firms are entering the birch triterpene market, employing innovative extraction, synthesis, and biotechnological production techniques, including microbial biosynthesis. Notable examples include:

BIRCKBI (BioTech): Focuses on microbial fermentation to produce betulin derivatives.
NaturaPharm: Develops plant cell culture protocols for sustainable production of betulinic acid.

These emerging suppliers offer potentially scalable and environmentally friendly options, though their regulatory and supply chain maturity varies.

Supply Chain Challenges and Opportunity

Supply Variability: Wild harvesting can introduce batch variability; standardized cultivation or biotechnology offers stability.
Environmental Regulations: Forest conservation policies impact raw material availability.
Geopolitical Factors: Tariffs, trade restrictions, and regional regulations influence sourcing options.

Investors and buyers should consider long-term contracts and strategic partnerships to mitigate supply risks, emphasizing suppliers with robust quality assurance and sustainable practices.

Conclusion

The pharmaceutical development of birch triterpenes relies on a select group of specialized suppliers capable of delivering high-quality, standardized, and sustainable extracts. Leading firms such as OlbrichtArom, Phytolab, and Indena have established reputations for supply excellence, backed by rigorous quality controls and regulatory compliance. With ongoing technological innovations and rising market demand, stakeholders should evaluate supplier capabilities carefully, balancing quality, sustainability, and scalability.

Key Takeaways

Reliable procurement of birch triterpenes demands suppliers with GMP certification, high purity standards, and sustainable sourcing practices.
Supercritical CO2 extraction technology is preferred for pharmaceutical-grade products due to environmental and purity considerations.
Collaborations with suppliers employing biotechnological production methods can offer greater supply stability and sustainability.
Market growth driven by natural therapeutics underscores the importance of strategic supplier relationships.
Maintaining regulatory compliance and quality consistency is critical for successful integration into pharmaceutical pipelines.

FAQs

1. What are the primary applications of birch triterpenes in pharmaceuticals?
Birch triterpenes are utilized for their anti-inflammatory, antiviral, anticancer, and hepatoprotective properties, often explored in formulations targeting cancer, skin diseases, and viral infections.

2. How is betulin extracted from birch bark?
Betulin is typically extracted using solvent-based methods or supercritical CO2 extraction, followed by purification and standardization processes to obtain pharmaceutical-grade purity.

3. Which regions are the main producers of birch triterpenes?
European countries like Germany and Italy, due to advanced herbal extract industries, and China, with large forestry resources, dominate production. Russia also contributes through sustainable wild harvesting.

4. Are there sustainable alternatives to wild harvesting for birch triterpenes?
Yes. Cultivation of birch trees specifically for extract production and biotechnological synthesis via microbial fermentation are increasingly employed to ensure sustainability.

5. What should buyers consider when choosing a supplier for pharmaceutical-grade birch triterpenes?
Buyers should verify certifications (GMP, ISO), analyze purity and consistency through CoA, assess extraction methods, and ensure adherence to environmental and regulatory standards.

Sources:

[1] MarketsandMarkets, "Betulin Market by Application & Region," 2022.
[2] OlbrichtArom, Corporate Brochure.
[3] Phytolab, Product Datasheets.
[4] Indena, Botanical Extracts Portfolio.
[5] Global Biotech Trends, "Sustainable Production of Birch Triterpenes," 2021.

Suppliers and packagers for generic pharmaceutical drug: BIRCH TRITERPENES